When People Wake Up After Their Organs Have Been Donated: Organ Donation, Death Panels, and the High Price for “Hopeless” Patients


When People Wake Up After Their Organs Have Been Donated: Organ Donation, Death Panels, and the High Price for “Hopeless” Patients

Austin, Texas — February 22, 2026
By Sherry Phipps

A small but disturbing set of recent and historic cases is raising new questions about how American hospitals determine death, approach organ donation, and talk to families when a patient is labeled “hopeless.” The ordeal of a Kentucky man who began moving on an operating table, the widely reported recovery of a 13‑year‑old Alabama boy whose organs were already promised to other children, and a New Mexico woman who blinked and moved moments before surgeons were due to remove her organs all highlight a troubling gap between official safeguards on paper and what some families say they experienced at the bedside.

When “Almost Dead” Is Not Dead

In Kentucky, the case of Anthony “TJ” Hoover has become a flashpoint in the national debate over organ donation and brain death protocols. In 2021, Hoover was rushed to Baptist Health Richmond after a cardiac arrest linked to a drug overdose and catastrophic brain injury, and his relatives were told his prognosis was effectively hopeless. Because he was a registered organ donor, his family agreed to honor his wishes, believing they were making a generous choice that could save other lives.

As part of the donation work‑up, Hoover was sent for a heart catheterization so clinicians could assess whether his heart and other organs were suitable for transplant. A preservation specialist later reported that, on the table, Hoover began moving and showing clear signs of responsiveness, “thrashing around” as staff examined him, and appeared to have tears on his face. According to reporting based on internal records and whistleblower testimony, one surgeon refused to proceed with organ recovery after seeing Hoover’s movements, but others allegedly continued to treat him as a donor rather than as a living patient until the procedure was halted.

Hoover survived and now lives with his sister, with ongoing impairments in speech, memory, and movement. Subsequent investigations by federal regulators and journalists identified additional cases linked to the same organ procurement organization in which documentation and neurological assessments did not fully align with best practices at the time organ recovery was being considered. For Hoover’s family and many observers, the horror lies less in what ultimately happened and more in how close the system came to treating a living man as a cadaver whose primary remaining value was his organs.

“Miracle” Patients Who Were Already Counted as Donors

Another case that continues to circulate years later involves 13‑year‑old Trenton McKinley of Mobile, Alabama. In 2018, Trenton sustained severe brain trauma when a utility trailer flipped and crushed his skull, leaving him with multiple skull fractures and an extended loss of vital signs. Reports say his heart stopped for about 15 minutes, and doctors told his mother that if he survived at all, he would almost certainly remain in a vegetative state with extremely low chances of meaningful recovery.​

Over days in intensive care, Trenton was described as “brain dead and barely breathing,” and his parents were asked to consider donating his organs to help other children. Believing there was no realistic hope, his mother signed papers authorizing donation of his organs to pediatric recipients who were a match. Before life support was withdrawn to the point that organ recovery could proceed, however, Trenton began showing signs of brain activity—first small movements, then more consistent responses.​

Soon afterward, he woke up and began speaking in full sentences, stunning both his family and his clinicians. He continues to live with seizures, nerve pain, and the effects of multiple surgeries, but he is conscious, communicative, and able to describe what he remembers. His story is often framed as a “miracle,” yet it also underscores how uncertain predictions about irreversible brain damage can be, especially for children and patients with complex disorders of consciousness. Parents in his case signed donor forms out of love and a desire to help others, only to learn that the line between irreversibly “gone” and slowly returning was far more uncertain than they had been led to believe.​

A New Mexico Woman Who Blinked Before the First Incision

In a more recent case reported by The New York Times and summarized by multiple outlets, 38‑year‑old Danella Gallegos, a homeless woman in Albuquerque, New Mexico, fell into a coma after a medical emergency in 2022 and was admitted to Presbyterian Hospital. Clinicians told her family that she was unlikely to recover, and New Mexico Donor Services became involved to coordinate organ donation after relatives agreed, believing she was beyond help.

As preparations for organ retrieval surgery moved forward, Gallegos’s family noticed tears in her eyes and later subtle movements, which donation coordinators reportedly dismissed as reflexes. On the day of the scheduled procedure, one of her sisters saw her move and alerted a physician, who asked Gallegos to blink if she could hear him—she did, clearly responding to a verbal command. The surgery was stopped and she was treated as a living patient rather than as a donor, and subsequent reports say she went on to make a meaningful recovery, contradicting the earlier portrayal of her condition as essentially hopeless.

For her family, the trauma was not only the initial crisis but also the realization that, without their insistence and a single doctor’s decision to test for responsiveness, Gallegos might have been cut open for organ retrieval while still alive. The case has intensified questions about how quickly “no meaningful recovery” can become “no recovery,” particularly for marginalized patients who may lack strong advocates at the bedside.

The Money on the Table

Concerns about pressure on families are intensified by the enormous amounts of money tied to organ transplantation. Estimates compiled by transplant advocacy organizations and hospital data show that the total billed cost of a single heart transplant in the United States can exceed one and a half million dollars, with liver, lung, and multi‑organ transplants routinely reaching into the high six‑ and seven‑figure range once surgery, intensive care, hospitalization, and early follow‑up are included. These charges do not mean that families are buying organs—federal law prohibits buying and selling human organs, and insurance or public programs typically cover the medical procedures—but every successful transplant generates a cascade of reimbursed services for hospitals, surgeons, anesthesiologists, transport teams, and post‑operative providers.​

Organ procurement organizations and transplant centers stress that they do not “profit from organs” and that payments cover services such as organ recovery, preservation, transport, and implantation rather than the organ itself. Legally and technically, that distinction matters. From a family’s perspective, though, the difference between being paid “for the organ” and being paid for all the processes surrounding that organ can feel like semantics when the same institutions promote donation heavily and then receive substantial reimbursement once surgery goes forward. Overall, organ transplantation functions as part of a multi‑billion‑dollar medical sector with complex financial relationships that can create conflicts of interest even when individual clinicians and staff have good intentions.​

This reality does not mean every transplant is corrupt or that every doctor is motivated by money. It does, however, challenge the idea that a lucrative, high‑demand area of medicine is uniquely insulated from the pressures, shortcuts, and rationalizations that affect other profit‑linked industries. In that context, assurances that “we only act after patients are definitely dead” sound very different to someone who has watched a supposedly dying patient stabilize, blink to command, or begin to move at the brink of organ recovery.

Protocols on Paper Versus Practice at the Bedside

Official statements from organ procurement organizations, major transplant centers, and educational campaigns emphasize that organ donation is tightly regulated, that organs are not removed until after a legal determination of death, and that “death panels” do not exist in U.S. hospitals. Policy documents outline specific criteria for declaring brain death—including loss of brainstem reflexes, apnea testing, and ruling out confounding drugs—as well as structured processes for donation after circulatory death. They also highlight ethics committees, consent procedures, and the “dead‑donor rule,” which holds that patients must be declared dead before their organs are recovered.​

The stories of Anthony Hoover, Trenton McKinley, and Danella Gallegos, along with other documented near‑misses, reveal a painful gap between those policies and what can unfold in real life. Under time pressure and with strong expectations from organ procurement organizations and transplant teams, criteria for brain death or circulatory death may be interpreted unevenly from case to case. Families may not fully understand the uncertain science around prognostication in severe brain injury, the limitations of current tools for assessing consciousness, or the difference between “no guarantee of recovery” and “zero chance of improvement.”

Consent processes, at least in theory, are designed to be free of coercion. In practice, families often find themselves in small rooms surrounded by multiple experts, hearing grim prognoses presented as near‑certainties and being told that their loved one’s organs could “save multiple lives” if only they agree. For those who have lived through these high‑pressure conversations, the phrase “death panel” is less a conspiracy slogan than a description of how the power dynamics and moral expectations can feel when the patient cannot speak for themselves and the family is outnumbered.

None of this erases the reality that organ donation saves lives for people on transplant waiting lists every day. It does, however, point to a need for a more candid public conversation about the uncertainty around declaring death in borderline cases, persistent inequities in health care, and the ways institutional incentives can subtly shape life‑and‑death choices at the bedside.

What Needs to Change

If the dead‑donor rule is to have real meaning in practice, several reforms appear urgent. First, advocates and ethicists are calling for transparent, enforceable national standards for determining brain death and managing donation after circulatory death, alongside mandatory, independent reviews of any case in which a patient shows unexpected signs of consciousness or recovery after donation planning has begun. Uniform criteria, applied consistently and audited externally, could reduce variability between hospitals and help identify systemic weaknesses before they lead to tragedy.

Second, many experts recommend stronger structural separation between teams that treat critically ill patients and those that coordinate organ procurement and transplantation. Clear firewalls in staffing, training, and financial incentives are intended to reduce the risk that decisions about prognosis, withdrawal of life support, or communication with families are influenced—consciously or unconsciously—by the prospect of obtaining organs.​

Third, hospitals may need to redesign how they conduct family meetings about withdrawal of life support and organ donation. Potential safeguards include limiting how many professionals are present, guaranteeing the presence of a truly independent patient or family advocate, requiring plain‑language explanations of uncertainty, and disclosing in writing the institutional and financial stakes associated with transplantation. These steps would not remove the emotional weight of the decisions, but they could make consent more informed and less driven by subtle pressure or one‑sided framing.​

Finally, accountability mechanisms need to respond when lines are crossed—or nearly crossed. Hospitals, organ procurement organizations, and individuals involved in near‑misses like Hoover’s halted procurement, McKinley’s premature consent, and Gallegos’s almost‑completed organ retrieval should face requirements for public reporting, corrective action plans, and, where appropriate, legal consequences. Treating such cases as rare but serious system failures, rather than embarrassing anomalies to be quietly buried, is critical for rebuilding public trust.

Until those changes are in place, families at the bedside cannot safely rely on idealized descriptions of how the organ donation system is supposed to work. They may need to ask direct questions, request copies of test results and second opinions, and, if anything feels rushed or wrong, withhold consent and seek outside help. The Kentucky man who moved on an operating table, the Alabama boy who woke up after his organs were promised away, and the New Mexico woman who blinked to command before the first incision offer a stark warning: in a system where the line between “hopeless” and “alive” can be drawn too quickly, the people most at risk are those least able to speak for themselves.